Halofuginone: From veterinary use to human therapy

Drug Development Research

Volumn 50, Issue 3-4, 2000, Pages 371-378

  Pines, Mark ^a   Vlodavsky, Israel ^b   Nagler, Arnon ^b  

^a VOLCANI CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Collagen; Fibrosis; Scleroderma; Tumor growth

Indexed keywords

COLLAGEN; FEBRIFUGINE; HALOFUGINONE; VETERINARY DRUG;

ANGIOGENESIS; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL MIGRATION; CLINICAL TRIAL; COLLAGEN DISEASE; COLLAGEN SYNTHESIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SCREENING; ENDOTHELIUM CELL; FIBROSIS; GENE EXPRESSION; GLIOMA; GRAFT VERSUS HOST REACTION; HUMAN; METABOLIC INHIBITION; NONHUMAN; PROSTATE CANCER; REVIEW; SCLERODERMA; SIDE EFFECT; TOXICITY TESTING; TREATMENT OUTCOME;

EID: 0033818915     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200007/08)50:3/4<371::aid-ddr19>3.0.co;2-r     Document Type: Review

References (57)

1. Stimulation of tumor angiogenesis by proximal wounds: Spatial and temporal analysis by MRI
2. Inhibition of neovascularization, tumor growth and facilitation of wound repair by halofuginone, an inhibitor of collagen type I synthesis
3. A connection between a dietary coccidiostat and skin tears of female broiler chickens
4. An antima-larial alkaloid from Hydrangea
5. Animal models of fibrosis
6. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intima hyperplasia
7. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases
8. Early events in angiogenesis: Cloning an alpha-prolyl 4-hydroxylase-like gene
9. Inhibition of bladder carcinoma angiogenesis, stromal support and tumor growth by halofuginone
10. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone
11. Kosher chickens, rabbit's ears, and scar-free future
12. Angiogenesis in cancer, vascular, rheumatoid and other disease
13. Blood vessels formation: What is its molecular basis?
14. Regulation of in-vitro capillary tube formation by anti-integrin antibodies
15. Skin tearing in broilers in relation to skin collagen: Effect of sex, strain, and diet
16. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone
17. Halofuginone: An inhibitor of collagen type I synthesis
18. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: Effect of halofuginone
19. Pathogenesis of progressive systemic sclerosis
20. Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients
21. The molecular basis and specificity of integrin-ligand interaction
22. Integrins: Versatility, modulation and signaling in cell adhesion
23. Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium
24. Chronic graft-versus-host-disease (GVHD) as a model for scleroderma. I. Description of model system
25. Ch'ang Shan, a Chinese antimalarian herb
26. Pharmacology of Ch'ang Shan (Dictoa febrifuga), a Chinese antimalarial herb
27. Collagens and their abnormalities in a wide spectrum of diseases
28. Post-translational processing of procollagens
29. Catalytic asymmetric synthesis of antimalarial alkaloids febrifugine and isofibrifugine and their biological activity
30. An alkaloid with high antimalarial activity from Dicroa febrifuga
31. Alkaloids of Dichroa febrifuga, Lour
32. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: Effect of halofuginone
33. Halofuginone inhibits neointimal formation of cultured rat aorta in a concentration-dependent fashion in vitro
34. Capillary endothelial cell cultures: Phenotypic modulation by matrix components
35. Control of coccidiosis chemotherapy
36. Topical treatment of cutaneous chronic graft versus host disease (cGvHD) with halofuginone: A novel inhibitor of collagen type I synthesis
37. Reduction in pulmonary fibrosis in vivo by halofuginone
38. Halofuginone - An inhibitor of collagen type I synthesis - Prevents post-operation abdominal adhesions formation
39. Inhibition of collagen synthesis, smooth muscle cell proliferation and injury-induced intimal hyperplasia by halofuginone
40. Halofuginone - An inhibitor of collagen type I synthesis - Prevents formation of post-operative adhesions formation in the rat uterine horn model
41. The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model
42. Topically applied halofuginone, an inhibitor of collagen type I transcription, reduced peritendinous fibrous adhesions following surgery
43. Procollagen gene expression by scleroderma fibroblasts in culture. Inhibition of collagen production and reduction of pro alpha 1(I) and pro alpha 1(III) collagen messenger RNA steady state levels by retinoids
44. Specific serum and local antibody responses against Cryptosporidium parvum during medication of calves with halofuginone lactate
45. Halofuginone - A novel anti-fibrotic therapy
46. Halofuginone - A novel anti-fibrotic therapy
47. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis
48. Collagens: Molecular biology, disease, and potentials for therapy
49. Cellular basis of radiation-induced fibrosis
50. Halofuginone: An inhibitor of collagen type I synthesis and angiogenesis inhibits brain tumor growth in vivo
51. The tight skin (Tsk) mutation in the mouse, a model for human fibrotic diseases, is tightly linked to the beta 2-microglobulin (B2m) gene on chromosome 2
52. Type IV collagenases in tumor invasion and metastasis
53. Defining the domains of type I collagen involved in heparin-binding and endothelial tube formation
54. New type of febrifugine analogues, bearing a quinolizidine moiety, show potent antimalarial activity against plasmodium malaria parasite
55. Pathogenesis of fibrosis: Type I collagen and the skin